Page 1 of 3

Biopharma Partnering Survey

This survey is part of our ongoing efforts to make biopharma partnering and collaborations more accessible, transparent, and efficient.

The questions are designed for out-licensors in the life science industry (biotechs and research institutes), to highlight their pain points and current partnering trends. Reminder, your responses will remain anonymous and your contact information will only be used to share the final report with you.

About You

What is your first name?

*

What is your last name?

*

What is your professional email address?

*

Which term best describes your organization?

*

Which term best describes your organization?

A

Biotech

B

Pharma

C

Research institute or TTO

D

Other

Organization name

*

Organization headquarters

*

Organization headquarters

A

North America

B

Europe

C

Asia Pacific

D

Other

Your Partnering Status

Your organization is: (select all that apply)

*

Your organization is: (select all that apply)

A

seeking to out-license asset(s)

B

seeking to in-license asset(s)

C

seeking other collaboration

D

Other

Your most advanced asset/technology category

*

Your most advanced asset/technology category

A

Pharma/Biologic

B

Platform/Technology

Asset type

*

Asset type

A

Small molecule

B

Antibody, protein, peptide

C

Cell therapy

D

Gene therapy

E

Antibiotics

F

Drug delivery

G

Discovery/development tool

H

Vaccine

I

Device

J

Diagnostic

K

Other

Your preferred deal type(s): (select all that apply)

*

Your preferred deal type(s): (select all that apply)

A

Research collaborations

B

Strategic alliances

C

Licensing agreements

D

Joint ventures

E

Co-development agreements

F

M&A

G

Equity investments

H

Other